Thompson Street Capital Partners

St. Louis, Missouri
cb
Founded:2000
Firm Location:St. Louis, Missouri • Panama City, Florida
Investor Firms That Co-Invest with Thompson Street Capital Partners
DeNAAccenturePractical Venture Capital
Thompson Street Capital Partners Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Jeff Aiello, Managing Director at Thompson Street Capital Partners
Jeff Aiello
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Craig Albrecht, Managing Director at Thompson Street Capital Partners
Craig Albrecht
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Joe Amadio, Managing Director at Thompson Street Capital Partners
Joe Amadio
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Elizabeth Borow, Managing Director at Thompson Street Capital Partners
Elizabeth Borow
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
+15
Photo of Cathy Bowers, Investor at Thompson Street Capital Partners
Cathy Bowers
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Max Cannon, Associate at Thompson Street Capital Partners
Max Cannon
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Consumer Internet (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Rick Clifton, Managing Director at Thompson Street Capital Partners
Rick Clifton
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Dan Cooper, Investor at Thompson Street Capital Partners
Dan Cooper
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Bob Dunn, Managing Partner at Thompson Street Capital Partners
Bob Dunn
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Kevin Fox, Vice President at Thompson Street Capital Partners
Kevin Fox
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Joe Jedlicka, Senior Associate at Thompson Street Capital Partners
Joe Jedlicka
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+15
Photo of Jesse Keipp, Managing Director at Thompson Street Capital Partners
Jesse Keipp
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Kevin Kerr, Vice President at Thompson Street Capital Partners
Kevin Kerr
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Infrastructure (Series B)
+17
Photo of Brian Kornmann, Managing Director at Thompson Street Capital Partners
Brian Kornmann
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Alex Mace, Vice President at Thompson Street Capital Partners
Alex Mace
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Photo of Clayton Milburn, Investor at Thompson Street Capital Partners
Clayton Milburn
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Fade Oluokun, Vice President at Thompson Street Capital Partners
Fade Oluokun
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Alison Schulte, Vice President at Thompson Street Capital Partners
Alison Schulte
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Midwest (Other Lists), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Jack Senneff, Managing Director at Thompson Street Capital Partners
Jack Senneff
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Photo of Bradley Strahorn, Investor at Thompson Street Capital Partners
Bradley Strahorn
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Photo of Ray Wagner, Managing Director at Thompson Street Capital Partners
Ray Wagner
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Vince Warrick, Managing Director at Thompson Street Capital Partners
Vince Warrick
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+18
Photo of J.C. Wetzel, Investor at Thompson Street Capital Partners
J.C. Wetzel
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17
Photo of Kelly Wittenbrink, Vice President at Thompson Street Capital Partners
Kelly Wittenbrink
Thompson Street Capital Partners
n/a
$25.0M
($5.0M - $50.0M)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B)
+17